Department of Translational Biomedicine Neuroscience, University of Bari "Aldo Moro", Piazza Giulio Cesare, 11, Bari, Italy.
Ophthalmology Department, San Raffaele University Hospital, Milan, Italy.
Sci Rep. 2023 Sep 28;13(1):16337. doi: 10.1038/s41598-023-43635-4.
The purpose of this study was to investigate the effect of diabetic retinopathy (DR) on longitudinal morphological changes in AMD-associated type 1 macular neovascularization using optical coherence tomography angiography (OCTA). We enrolled fifty treatment-naïve eyes with a diagnosis of exudative AMD and type 1 MNV. Twenty of 50 eyes were affected by mild DR. En face OCT angiography were examined for the MNV lesion area (mm), the MNV flow area (mm), the central macular thickness (CMT) and the BCVA. The OCTA acquisition was performed at the following visits: (i) before the loading phase (LP) of intravitreal injection of aflibercept (T1), and (ii) 1 month after the last intravitreal injection of loading phase comprising 3 monthly injections (T2). All morpho-functional parameters showed a significantly change at T2 compared to T1 values in both groups. Furthermore, we found a greater MNV area reduction after LP in eyes without DR (P = 0.023). With regard to the remaining parameters, no significant changes were found between two groups (P > 0.05). Our analysis revealed a less MNV area reduction after loading dose of anti-VEGF therapy in eyes affected by diabetic retinopathy.
本研究旨在通过光相干断层扫描血管造影(OCTA)研究糖尿病性视网膜病变(DR)对 AMD 相关 1 型黄斑新生血管(MNV)纵向形态变化的影响。我们纳入了 50 例未经治疗的渗出性 AMD 和 1 型 MNV 患者的 50 只治疗初治眼。20 只眼受轻度 DR 影响。对视盘面积(mm)、MNV 血流面积(mm)、中央视网膜厚度(CMT)和 BCVA 进行了基于 OCT 的血管造影检查。在以下访视时进行 OCTA 采集:(i)玻璃体腔内注射阿柏西普负荷期前(T1),和(ii)最后一次玻璃体腔内注射负荷期(包括 3 次每月注射)后 1 个月(T2)。与两组的 T1 值相比,所有形态功能参数在 T2 时均显示出显著变化。此外,我们发现无 DR 眼在 LP 后 MNV 面积减少更大(P=0.023)。至于其余参数,两组之间未发现明显变化(P>0.05)。我们的分析显示,糖尿病视网膜病变眼在接受抗 VEGF 治疗负荷剂量后,MNV 面积减少较少。